Experienced in Congenital Aplastic Anemia

Dr. Ambuga R. Badari

Hematology Oncology | Hematology | Oncology
Ochsner Clinic LLC
1514 Jefferson Hwy, 
New Orleans, LA 
 (1091 mi)
Clinical Trials:Currently Recruiting for 1 Trial
Accepting New Patients
Offers Telehealth
Experienced in Congenital Aplastic Anemia
Ochsner Clinic LLC
1514 Jefferson Hwy, 
New Orleans, LA 
 (1091 mi)
OverviewInsuranceLocationsClinical Research

Overview

Ambuga Badari is a Hematologist Oncology specialist and a Hematologist in New Orleans, Louisiana. Dr. Badari and is rated as an Experienced provider by MediFind in the treatment of Congenital Aplastic Anemia. His top areas of expertise are Thrombocytopenia, Multiple Myeloma, Non-Hodgkin Lymphoma, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Badari is currently accepting new patients.

His clinical research consists of co-authoring 5 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Hematology Oncology
Hematology
Oncology
Hospital Affiliations
Terrebonne General Medical Center - Parish
Ochsner Medical Center Acute
Slidell Memorial Hospital
Ochsner Medical Center - Baton Rouge
Ochsner Lafayette General Medical Center
Languages Spoken
English
Georgian
Hindi
Kannada
Tamil
Gender
Male

Insurance

Please contact the provider to confirm they accept your insurance or if you don't see your insurance listed.

Accepted insurance plans

  •  Cigna
  •  Blue Cross Blue Shield
  •  Humana

Locations

OCHSNER CLINIC LLC
1514 Jefferson Hwy, New Orleans, LA 70121

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase II Study of Inotuzumab Ozogamicin Followed by Blinatumomab for Ph-Negative CD22-Positive B-Lineage Acute Lymphoblastic Leukemia in Newly Diagnosed Older Adults or Adults With Relapsed or Refractory Disease
A Phase II Study of Inotuzumab Ozogamicin Followed by Blinatumomab for Ph-Negative CD22-Positive B-Lineage Acute Lymphoblastic Leukemia in Newly Diagnosed Older Adults or Adults With Relapsed or Refractory Disease
Enrollment Status: Recruiting
Publish Date: February 26, 2025
Intervention Type: Biological
Study Drugs: Blinatumomab, Inotuzumab
Study Phase: Phase 2
A Phase I/II Clinical Study Evaluating the Safety and Effectiveness of BIO 300 Oral Suspension in Patients Receiving Chemoradiation Therapy for Non-Small Cell Lung Cancer (NSCLC)
A Phase I/II Clinical Study Evaluating the Safety and Effectiveness of BIO 300 Oral Suspension in Patients Receiving Chemoradiation Therapy for Non-Small Cell Lung Cancer (NSCLC)
Enrollment Status: Completed
Publish Date: January 25, 2024
Intervention Type: Drug, Radiation
Study Phase: Phase 1/Phase 2
View 1 Less Clinical Trial

5 Total Publications

Pericardial Relapse of Acute Lymphoblastic Leukemia (ALL).
Pericardial Relapse of Acute Lymphoblastic Leukemia (ALL).
Journal: Case reports in oncological medicine
Published: March 23, 2021

Areas of Expertise

When evaluating expertise, MediFind pulls from factors such as the number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

To learn more about how MediFind determines the expertise levels, check out our expert tiers page.

Search for your specific condition
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile